PL EN


Preferences help
enabled [disable] Abstract
Number of results
2016 | 12 | 1 | 10–19
Article title

Jak zapobiec odległym następstwom choroby nerek z okresu dzieciństwa?

Content
Title variants
EN
Averting the legacy of kidney disease – focus on childhood
Languages of publication
EN PL
Abstracts
EN
World Kidney Day 2016 focuses on kidney disease in childhood and the antecedents of adult kidney disease that can begin in earliest childhood. Chronic kidney disease in childhood differs from that in adults, as the largest diagnostic group among children includes congenital anomalies and inherited disorders, with glomerulopathies and kidney disease in the setting of diabetes being relatively uncommon. In addition, many children with acute kidney injury will ultimately develop sequelae that may lead to hypertension and chronic kidney disease in later childhood or in adult life. Children born early or who are small-for date newborns have relatively increased risk for the development of chronic kidney disease later in life. Persons with a high-risk birth and early childhood history should be watched closely in order to help detect early signs of kidney disease in time to provide effective prevention or treatment. Successful therapy is feasible for advanced chronic kidney disease in childhood; there is evidence that children fare better than adults, if they receive kidney replacement therapy including dialysis and transplantation, while only a minority of children may require this ultimate intervention. Because there are disparities in access to care, effort is needed so that those children with kidney disease, wherever they live, may be treated effectively, irrespective of their geographic or economic circumstances. Our hope is that World Kidney Day will inform the general public, policy makers and caregivers about the needs and possibilities surrounding kidney disease in childhood.
PL
W 2016 roku obchody Światowego Dnia Nerek koncentrują się na chorobach występujących u dzieci i zdarzeniach nawet z najwcześniejszego dzieciństwa, które mogą stać się podłożem przewlekłego schorzenia u dorosłych. U dzieci choroba nerek przybiera nieco inną formę niż u dorosłych – dużą grupę najmłodszych pacjentów stanowią ci z wadami wrodzonymi i genetycznymi układu moczowego, glomerulopatiami oraz (rzadziej) chorobami nerek na podłożu cukrzycy. U wielu dzieci z ostrym uszkodzeniem nerek pojawiają się następstwa w postaci nadciśnienia tętniczego i przewlekłej choroby nerek w późniejszym dzieciństwie albo wieku dorosłym. Wcześniaki i stosunkowo małe noworodki cechują się podwyższonym ryzykiem wystąpienia przewlekłej choroby nerek w późniejszym życiu. Pacjentów z obciążonym wywiadem okołoporodowym i dotyczącym wczesnego dzieciństwa należy ściśle monitorować w celu rozpoznania pierwszych oznak choroby i wdrożenia efektywnej profilaktyki lub leczenia. Możliwa jest skuteczna terapia przewlekłej choroby nerek u dzieci, które – jak wskazują badania – znacznie lepiej niż dorośli radzą sobie z uciążliwością leczenia nerkozastępczego, w tym programu dializ i przeszczepienia. Ponieważ dostęp do specjalistycznej opieki nefrologicznej nie jest jednolity, należy wdrożyć odpowiednie działania, aby zapewnić skuteczne leczenie wszystkim chorym dzieciom, bez względu na ich miejsce zamieszkania czy status ekonomiczny. Żywimy nadzieję, że Światowy Dzień Nerek pomoże w edukacji opinii publicznej, ustawodawców i pracowników służby zdrowia w zakresie potrzeb związanych z chorobą nerek występującą w dzieciństwie.
Discipline
Year
Volume
12
Issue
1
Pages
10–19
Physical description
References
  • 1. Goldstein SL: Acute kidney injury in children and its potential consequences in adulthood. Blood Purif 2012; 33: 131–137.
  • 2. Harambat J, van Stralen KJ, Kim JJ et al.: Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012; 27: 363–373.
  • 3. Warady BA, Chadha V: Chronic kidney disease in children: the global perspective. Pediatr Nephrol 2007; 22: 1999–2009.
  • 4. Furth SL, Cole SR, Moxey-Mims M et al.: Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 2006; 1: 1006–1015.
  • 5. Health statistics and information systems: Estimates for 2000–2012. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html.
  • 6. NAPRTCS Annual Reports. Available from: https://web.emmes.com/study/ped/annlrept/annlrept.html.
  • 7. Saran R, Li Y, Robinson B et al.: US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2015; 66 (Suppl 1): Svii.
  • 8. ESPN/ERA-EDTA Registry, European Registry for Children on Renal Replacement Therapy. Available from: http://www.espnreg.org/index.jsp.
  • 9. Ardissino G, Daccò V, Testa S et al.: Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics 2003; 111: e382–e387.
  • 10. Wong CJ, Moxey-Mims M, Jerry-Fluker J et al.: CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis 2012; 60: 1002–1011.
  • 11. Global Burden of Disease Study 2013 Collaborators: Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386: 743–800.
  • 12. Coca SG, Singanamala S, Parikh CR: Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012; 81: 442–448.
  • 13. Basu RK, Kaddourah A, Terrell T et al.; Prospective Pediatric AKI Research Group (ppAKI): Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol 2015; 16: 24.
  • 14. Eckardt KU, Coresh J, Devuyst O et al.: Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 2013; 382: 158–169.
  • 15. Wuhl E, van Stralen KJ, Verrina E et al.: Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol 2013; 8: 67–74.
  • 16. ESCAPE Trial Group, Wühl E, Trivelli A, Picca S et al.: Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361: 1639–1650.
  • 17. van Stralen KJ, Borzych-Dużalka D, Hataya H et al.; ESPN/ERAEDTA registry; IPPN registry; ANZDATA registry; Japanese RRT registry: Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int 2014; 86: 168–174.
  • 18. Querfeld U, Anarat A, Bayazit AK et al.; 4C Study Group: The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol 2010; 5: 1642–1648.
  • 19. Hoy WE, Ingelfinger JR, Hallan S et al.: The early development of the kidney and implications for future health. J Dev Orig Health Dis 2010; 1: 216–233.
  • 20. Flynn JT, Ng DK, Chan GJ et al.; Chronic Kidney Disease in Children Study: The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease. J Pediatr 2014; 165: 154–162e1.
  • 21. Rodriguez MM, Gómez AH, Abitbol CL et al.: Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 2004; 7: 17–25.
  • 22. Abitbol CL, Bauer CR, Montané B et al.: Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 2003; 18: 887–893.
  • 23. Hodgin JB, Rasoulpour M, Markowitz GS et al.: Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2009; 4: 71–76.
  • 24. Verhave JC, Wetzels JF, van de Kar NC: Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab. Nephrol Dial Transplant 2014; 29 Suppl 4: iv131–iv141.
  • 25. Torres VE: Vasopressin receptor antagonists, heart failure, and polycystic kidney disease. Annu Rev Med 2015; 66: 195–210.
  • 26. Jarzembowski T, John E, Panaro F et al.: Impact of non-compliance on outcome after pediatric kidney transplantation: an analysis in racial subgroups. Pediatr Transplant 2004; 8: 367–371.
  • 27. Watson AR: Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 2000; 14: 469–472.
  • 28. Aujoulat I, Deccache A, Charles AS et al.: Non-adherence in adolescent transplant recipients: the role of uncertainty in health care providers. Pediatr Transplant 2011; 15: 148–156.
  • 29. Watson AR, Harden PN, Ferris ME et al.; International Society of Nephrology; International Pediatric Nephrology Association: Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int 2011; 80: 704–707.
  • 30. Watson AR, Harden P, Ferris M et al.: Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol 2011; 26: 1753–1757.
  • 31. Gallieni M, Aiello A, Tucci B et al.: The burden of hypertension and kidney disease in Northeast India: the Institute for Indian Mother and Child noncommunicable diseases project. ScientificWorldJournal 2014; 2014: 320869.
  • 32. White A, Wong W, Sureshkumur P et al.: The burden of kidney disease in indigenous children of Australia and New Zealand, epidemiology, antecedent factors and progression to chronic kidney disease. J Paediatr Child Health 2010; 46: 504–509.
  • 33. Zarocostas J: Need to increase focus on non-communicable diseases in global health, says WHO. BMJ 2010; 341: c7065.
  • 34. Gulland A: WHO agrees to set up body to act on non-communicable diseases. BMJ 2013; 346: f3483.
  • 35. Feehally J: Chronic kidney disease: Health burden of kidney disease recognized by UN. Nat Rev Nephrol 2011; 8: 12–13.
  • 36. Couser WG, Remuzzi G, Mendis S et al.: The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80: 1258–1270.
Document Type
communication
Publication order reference
YADDA identifier
bwmeta1.element.psjd-8036dd72-d43a-4e17-be86-a44c4f535d3a
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.